Home » Miltenyi Biotec, GSK Enter Cell and Gene Therapy Development Partnership
Miltenyi Biotec, GSK Enter Cell and Gene Therapy Development Partnership
GlaxoSmithKline and Miltenyi Biotec are partnering to develop a cell and gene therapy platform, the companies announced last week.
Their collaboration will focus on discovering new chimeric antigen-receptor T-cell based therapeutics, with an eye toward optimizing manufacture and delivery to support the development of novel therapies in oncology and rare diseases.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May